Company: INTS
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001567264-25-000010
Chunk: 33

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 33
---
 independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.  Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.  We believe that our audits provide a reasonable basis for our opinion.

We have served as the Company’s auditor since 2017.

/s/ EisnerAmper LLP

EISNERAMPER LLP

New York, New York

March 13, 2025

F-2

INTENSITY THERAPEUTICS, INC.

BALANCE SHEETS

(in thousands, except share and per share amounts)

December 31,20242023ASSETSCurrent assets:Cash and cash equivalents$2,590 $8,556 Marketable debt securities— 6,220 Prepaid expenses and other current assets773 688 Total current assets3,363 15,464 Right-of-use asset, net122 147 Other assets1,298 1,684 Total assets$4,783 $17,295 LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent liabilities:Accounts payable$1,219 $3,048 Accrued expenses508 891 Lease liability, current portion28 20 Total current liabilities1,755 3,959 Other long-term liabilities— 36 Lease liability, net of long-term portion110 138 Total liabilities$1,865 $4,133 Commitments and conting